FOXM1 and lip and oral cavity carcinoma: They demonstrated that the overexpression of FOXM1 protein induced by cisplatin causes resistance to paclitaxel, which can potentially attenuate the effectiveness of the combination with the two chemotherapeutic agents for oral cancer.